Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Impairment and disability in 20 CIDP patients according to disease activity status.
Allopregnanolone: State of the art.
Palliative treatment of chronic neurologic disorders.
Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis.
Ten Years of Proteomics in Multiple Sclerosis.
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation.
Osthole augments therapeutic efficiency of neural stem cells-based therapy in experimental autoimmune encephalomyelitis.
Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis.
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study.
The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS.
Relapsing remitting multiple sclerosis in x-linked charcot-marie-tooth disease with central nervous system involvement.
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
From genetic associations to functional studies in multiple sclerosis.
Development and aging of superficial white matter myelin from young adulthood to old age: Mapping by vertex-based surface statistics (VBSS).
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Direct MRI detection of impending plaque development in multiple sclerosis.
Evolution of myelin ultrastructure and the major structural myelin proteins.
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy.
Erratum.
Relationship between gait initiation and disability in individuals affected by multiple sclerosis.
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
Pages
« first
‹ previous
…
618
619
620
621
622
623
624
625
626
…
next ›
last »